Alignment Healthcare, Inc. — Form 8-K Summary
Filing date: October 8, 2026. The filing reports CMS’s release of 2027 Medicare Advantage and Part D Star Ratings. It is a ratings update, not a financial-results filing.
Business context and reporting period
CMS released the 2027 Star Ratings on October 8, 2026. The filing concerns the ratings and their expected effects on Alignment’s health plans and fiscal 2028 quality bonus payments.
Key financial and operating metrics
- Alignment expects California HMO contract H3815, serving approximately 75% of membership, to receive 3.5 stars for rating year 2027, down from 4.0 stars for rating year 2026.
- The company expects each of its six other eligible plans to retain a 4.0-star rating or higher; three achieved 4.5 stars.
- The 2027 ratings are not expected to affect revenue in fiscal 2026 or 2027. The change is expected to affect quality bonus payments in fiscal 2028; the filing does not provide a dollar estimate.
- Provider risk-sharing arrangements are expected to offset a portion of the potential fiscal 2028 impact. No specific offset amount or other financial statements, cash flow, debt, or liquidity figures are provided.
- Approximately 50% of members joined Alignment within the last two years. The company expects earnings growth from existing membership to support its margin trajectory over coming years.
Material changes versus prior period
H3815’s expected rating declines by half a star from 4.0 for rating year 2026 to 3.5 for 2027. The filing attributes the decline primarily to higher industry cut points and weaker performance on certain triple-weighted Health Outcomes Survey and Part D measures. CMS’s retroactive elimination of bonus calculations tied to the Excellent Health Outcomes for All Index also reduced the impact of investments made under the prior implementation.
Outlook, commentary, risks, and contingencies
- Alignment says it is pursuing enterprise-wide member and provider engagement, care-gap closure, and quality-oversight initiatives, and believes these efforts can help return H3815 to at least 4.0 stars in future rating years.
- The company intends to pursue available administrative appeals and expects to litigate certain Star Ratings measures and methodologies it believes conflict with applicable law or CMS’s statutory authority. Outcomes are uncertain.
- Alignment says it is aggressively pursuing options to mitigate potential fiscal 2028 financial impacts. No quantified mitigation target is disclosed.
- Forward-looking outcomes depend on factors including future plan ratings, success of appeals, litigation and mitigation actions, membership and earnings growth, provider relationships, regulation, indebtedness, litigation or security incidents, and labor availability and costs.
Important facts for investors to verify
- Final CMS rating details for H3815 and the other eligible plans, including any changes following appeals.
- The amount of any fiscal 2028 quality-bonus reduction and how much provider risk-sharing arrangements offset it.
- Progress and results of the company’s administrative appeals and planned litigation.
- Whether quality initiatives improve H3815’s rating and whether existing-member earnings growth supports the stated margin outlook.